CrystalGenomics gets U.S. patent on novel cancer candidate
Published: 2011-11-16 06:56:00
Updated: 2011-11-16 06:56:00
CrystalGenomics, a high-flying Korean biotechnology venture, announced Friday in its regulatory filing that the U.S. Patent and Trademark Office issued the company a patent covering the investigational cancer candidate (code name: CG200745).
The company said it has filed for an international p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
